Literature DB >> 19696064

Medical vs surgical treatment for the native joint in septic arthritis: a 6-year, single UK academic centre experience.

Vinod Ravindran1, Ian Logan, Brian E Bourke.   

Abstract

OBJECTIVE: Medical treatment (serial closed-needle aspiration) and surgical treatment (arthroscopy/arthrotomy combined with joint washout) are well-recognized methods to treat septic arthritis (SA) of native joints. We compared the outcome of proven SA based on the method of treatment.
METHODS: We reviewed case notes of adult patients who were admitted to our institution from January 2001 to December 2006 with proven SA (Newman Grade A organism isolated from the joint).
RESULTS: Thirty-two episodes were treated medically and 19 surgically (4 with arthrotomy, 15 with arthroscopy) in the study period. All had mono-articular SA. No significant difference in the age, symptom duration before treatment and duration of intravenous antibiotic therapy was present between the two groups. Medical treatment resulted in complete recovery in more patients (69 vs 53%, P = 0.24) but longer period of hospitalization [median (interquartile range), 16.5 (14-19) vs 15 (11-17), P = 0.34], although the difference between the groups was not significant. More surgically treated patients had deterioration in functional status at the time of discharge from the hospital (29 vs 44%, P = 0.27), but the difference between the groups was not statistically significant. Surgically treated patients required significantly more sessions of physiotherapy (mean +/- S.D., 7 +/- 2 vs 10 +/- 3, P = 0.002). Mortality was similar (one in each group).
CONCLUSION: Results from this study show that for the native joint SA, surgical treatment was not superior to the medical treatment and, therefore, highlight the need for careful case selection for surgical intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696064     DOI: 10.1093/rheumatology/kep220

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  23 in total

1.  Bone and joint infection.

Authors:  Julia Colston; Bridget Atkins
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

2.  Therapy: Optimum therapy in septic arthritis: to cut or not to cut?

Authors:  Max Field
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

3.  What are we doing about septic arthritis? A survey of UK-based rheumatologists and orthopedic surgeons.

Authors:  Usman Butt; Maame Amissah-Arthur; Fazal Khattak; Chris F Elsworth
Journal:  Clin Rheumatol       Date:  2011-01-11       Impact factor: 2.980

4.  [Septic arthritis in adults].

Authors:  J Loock; N Haustedt; J Wollenhaupt
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

5.  Bilateral, simultaneous pneumococcal septic arthritis of the knees: a normal immune system, an unknown source.

Authors:  Thomas Ian Whitehead-Clarke; Raj Singavarapu; Abhinav Gulihar; Krissen Chettiar
Journal:  BMJ Case Rep       Date:  2016-05-05

6.  What's New in the Management of Bacterial Septic Arthritis?

Authors:  Sumeet Chander; Gerald Coakley
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

Review 7.  [Infections of non-prosthetically treated joints].

Authors:  O Hauschild; N P Südkamp
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

Review 8.  Clinical management of septic arthritis.

Authors:  Katie A Sharff; Eric P Richards; John M Townes
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

9.  Septic arthritis secondary to rat bite fever: a challenging diagnostic course.

Authors:  Basil Budair; Karan Goswami; Vivek Dhukaram
Journal:  BMJ Case Rep       Date:  2014-04-02

10.  Clinical characteristics and outcomes of patients with septic arthritis treated without surgery.

Authors:  Sarah B Lieber; Noa Alpert; Mary Louise Fowler; Robert H Shmerling; Ziv Paz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-02       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.